151 related articles for article (PubMed ID: 30719155)
21. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
[TBL] [Abstract][Full Text] [Related]
22. Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based study.
Bao S; Jiang M; Wang X; Hua Y; Zeng T; Yang Y; Yang F; Yan X; Sun C; Yang M; Fu Z; Huang X; Li J; Wu H; Li W; Tang J; Yin Y
Cancer Med; 2021 Dec; 10(23):8662-8672. PubMed ID: 34643330
[TBL] [Abstract][Full Text] [Related]
23. A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.
Li D; Zhong C; Cheng Y; Zhu N; Tan Y; Zhu L; Xu D; Yuan Y
J Cancer; 2019; 10(27):6801-6812. PubMed ID: 31839814
[No Abstract] [Full Text] [Related]
24. Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis.
Huang H; Li Z; Huang Z; Huang L; Liu W; Liu G; Mo Y
Front Oncol; 2023; 13():1076997. PubMed ID: 37152061
[TBL] [Abstract][Full Text] [Related]
25. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
[TBL] [Abstract][Full Text] [Related]
26. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
27. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
[TBL] [Abstract][Full Text] [Related]
28. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
29. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
30. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
31. A Novel Nomogram for Predicting Breast Cancer-specific Survival in Male Patients.
Zhou Q; Zhang Q; Zhao S; Zhang Y; Wang Q; Li J
Am J Clin Oncol; 2022 Oct; 45(10):427-437. PubMed ID: 36106711
[TBL] [Abstract][Full Text] [Related]
32. Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.
Li X; Hu M; Gu W; Liu D; Mei J; Chen S
Front Oncol; 2021; 11():698870. PubMed ID: 34722245
[TBL] [Abstract][Full Text] [Related]
33. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
[TBL] [Abstract][Full Text] [Related]
34. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
35. A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.
Hu M; Li X; Gu W; Mei J; Liu D; Chen S
Front Oncol; 2021; 11():698955. PubMed ID: 34504784
[TBL] [Abstract][Full Text] [Related]
36. Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis.
Shen W; Sakamoto N; Yang L
J Cancer; 2018; 9(21):4009-4017. PubMed ID: 30410606
[No Abstract] [Full Text] [Related]
37. Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Yu X; Gao S; Xue Q; Tan F; Gao Y; Mao Y; Wang D; Zhao J; Li Y; He J; Mu J
J Thorac Dis; 2020 May; 12(5):2583-2594. PubMed ID: 32642166
[TBL] [Abstract][Full Text] [Related]
38. Development of a competing risk nomogram for the prediction of cause-specific mortality in patients with thymoma: a population-based analysis.
Zhang T; Liu L; Qiu B
J Thorac Dis; 2021 Dec; 13(12):6838-6847. PubMed ID: 35070368
[TBL] [Abstract][Full Text] [Related]
39. Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015.
Ma Y; Yang Z; Gao Y; Li K; Qiu P; Chen H; Pu S; Wang B; Zhou C
Front Oncol; 2020; 10():583488. PubMed ID: 33552959
[TBL] [Abstract][Full Text] [Related]
40. Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study.
Zhou X; Qiu S; Jin K; Yuan Q; Jin D; Zhang Z; Zheng X; Li J; Wei Q; Yang L
Front Surg; 2021; 8():770169. PubMed ID: 34901145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
